Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
1Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
SpyGlass Pharma, Inc. (SGP) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
3Total relationships
0Distinct source URLs
2High confidence
0.790Average confidence
2026-10-08Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from MRK graph: vable arise from product sales in the U.S. and Europe and are primarily due from drug wholesalers, distributors and retailers, hospitals and government agencie…
Reciprocal relationship from GEG graph: Reciprocal relationship from SGP graph: Reciprocal relationship from GEG graph: SGP owns 1,092,028 shares of GECC as of June 30, 2025.
SpyGlass Pharma, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
SGP-DEBT
Debt stack $1.6M
90%
Market cache reports total debt of $1.6M.
SpyGlass Pharma, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for SpyGlass Pharma, Inc..
SpyGlass Pharma, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for SpyGlass Pharma, Inc..
SpyGlass Pharma, Inc. Extended Supply Chain Network